MiMedx Group MDXG Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $166.12M+59.1% | $104.42M+27.3% | $82M+24.3% | $65.95M-24.3% | ||
| $307.35M+32.4% | $232.11M+11.6% | $208.05M+21.2% | $171.72M+13.3% | ||
| $25.34M+6.4% | $23.81M+13.3% | $21.02M+59.5% | $13.18M+15.8% | ||
| $277.47M+44.6% | $191.89M+16.8% | $164.26M+22.4% | $134.2M-9.6% | ||
| $4.71M-20.7% | $5.94M-14.8% | $6.97M-11.2% | $7.86M-14.3% | ||
| $19.44M0.0% | $19.44M0.0% | $19.44M0.0% | $19.44M0.0% | ||
| $13.12M+12.8% | $11.63M+121% | $5.26M-10.2% | $5.85M+8.7% | ||
| $342.65M+29.8% | $263.92M+10.4% | $239.05M+39.4% | $171.43M-8.8% | ||
| $14.53M+96.1% | $7.41M-18.1% | $9.05M+7.0% | $8.45M+14.5% | ||
| $1.5M+50.0% | $1M0.0% | $1M— | —— | ||
| $64.27M+40.9% | $45.6M-0.9% | $46.01M+5.6% | $43.56M+2.8% | ||
| $16.47M-7.6% | $17.83M-62.9% | $48.1M-1.0% | $48.59M+1.0% | ||
| $86.11M+21.6% | $70.81M-26.5% | $96.33M-0.6% | $96.92M+1.6% | ||
| 250M+169,968% | 147K-99.9% | 250M+219,198% | 114K+0.9% | ||
| -$42.68M+53.2% | -$91.26M+31.7% | -$133.68M+30.3% | -$191.91M-18.7% | ||
| $256.55M+32.9% | $193.11M+35.3% | $142.72M+893% | -$17.99M-22,037% | ||
| $342.65M+29.8% | $263.92M+10.4% | $239.05M+39.4% | $171.43M-8.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are MiMedx Group's total assets?
- MiMedx Group (MDXG) holds $308.7M in total assets, up 14.1% year over year.
- How much debt does MiMedx Group have?
- MiMedx Group carries $17.6M in total debt against $242.9M of shareholders' equity, a debt-to-equity ratio of 0.07.
- How much cash does MiMedx Group have?
- MiMedx Group holds $159.8M in cash and equivalents.
- Can MiMedx Group cover its short-term obligations?
- Its current ratio is 5.39 — current assets exceed current liabilities.
- Where does MiMedx Group's balance sheet data come from?
- Every line is extracted from MiMedx Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
